Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats
2011

Effects of Stem Cell Transplantation on Stroke Recovery in Rats

Sample size: 78 publication Evidence: moderate

Author Information

Author(s): Liu Nan, Zhang Yixian, Fan Lin, Yuan Mingzhou, Du Houwei, Cheng Ronghua, Liu Deshan, Lin Feifei

Primary Institution: Union Hospital, Fujian Medical University

Hypothesis

Can transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin improve recovery from cerebral ischemia in rats?

Conclusion

Modification with Survivin enhances the therapeutic effects of mesenchymal stem cells by improving their survival and increasing protective cytokine expression in ischemic tissue.

Supporting Evidence

  • Survivin-modified MSCs showed increased survival rates compared to unmodified MSCs.
  • Transplantation with SVV/GFP-MSCs reduced infarct volume by 5.2% compared to GFP-MSCs.
  • Neurological function improved significantly in the SVV group compared to the control group.

Takeaway

This study shows that special stem cells can help rats recover from a stroke better when they are modified with a protein called Survivin.

Methodology

Rats underwent middle cerebral artery occlusion and were treated with modified stem cells; their recovery was assessed through various tests.

Limitations

The study did not determine if Survivin changes the differentiation of stem cells into neurons or how it affects the expression of protective factors.

Participant Demographics

Adult male Sprague-Dawley rats weighing 220-250 g.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1479-5876-9-105

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication